Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study.
Mackman RL, Sangi M, Sperandio D, Parrish JP, Eisenberg E, Perron M, Hui H, Zhang L, Siegel D, Yang H, Saunders O, Boojamra C, Lee G, Samuel D, Babaoglu K, Carey A, Gilbert BE, Piedra PA, Strickley R, Iwata Q, Hayes J, Stray K, Kinkade A, Theodore D, Jordan R, Desai M, Cihlar T. Mackman RL, et al. Among authors: theodore d. J Med Chem. 2015 Feb 26;58(4):1630-43. doi: 10.1021/jm5017768. Epub 2015 Jan 27. J Med Chem. 2015. PMID: 25574686 Clinical Trial.
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive Messaging.
Paras ML, Chirch LM, Aziz M, Balba GP, Benson C, Butt S, James SH, McCarty TP, Razonable R, Reece R, Shnekendorf R, Swartz TH, Viehman JA, Luther VP; Infectious Diseases Society of America Fellowship Training Program Directors Community of Practice and Working Group (complete list of contributing authors in the Working Group listed in acknowledgments). Paras ML, et al. Open Forum Infect Dis. 2024 Nov 12;11(12):ofae669. doi: 10.1093/ofid/ofae669. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39610405 Free PMC article.
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.
Buti M, Heo J, Tanaka Y, Andreone P, Atsukawa M, Cabezas J, Chak E, Coffin CS, Fujiwara K, Gankina N, Gordon SC, Janczewska E, Komori A, Lampertico P, McPherson S, Morozov V, Plesniak R, Poulin S, Ryan P, Sagalova O, Sheng G, Voloshina N, Xie Q, Yim HJ, Dixon S, Paff M, Felton L, Lee M, Greene T, Lim J, Lakshminarayanan D, McGonagle G, Plein H, Youssef AS, Elston R, Kendrick S, Theodore D. Buti M, et al. Among authors: theodore d. J Hepatol. 2024 Aug 29:S0168-8278(24)02488-7. doi: 10.1016/j.jhep.2024.08.010. Online ahead of print. J Hepatol. 2024. PMID: 39214467 Free article.
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.
Shoemaker K, Soboleva K, Branche A, Shankaran S, Theodore DA, Bari M, Ezeh V, Green J, Kelly E, Lan D, Olsson U, Saminathan S, Shankar NK, Villegas B, Villafana T, Falsey AR, Sobieszczyk ME. Shoemaker K, et al. Among authors: theodore da. Vaccines (Basel). 2024 Aug 3;12(8):883. doi: 10.3390/vaccines12080883. Vaccines (Basel). 2024. PMID: 39204009 Free PMC article.
Correlates of verbal and physical violence experienced and perpetrated among cisgender college women: serial cross-sections during one year of the COVID-19 pandemic.
Theodore DA, Heck CJ, Huang S, Huang Y, Autry A, Sovic B, Yang C, Anderson-Burnett SA, Ray C, Austin E, Rotbert J, Zucker J, Catallozzi M, Castor D, Sobieszczyk ME. Theodore DA, et al. Front Reprod Health. 2024 Jul 25;6:1366262. doi: 10.3389/frph.2024.1366262. eCollection 2024. Front Reprod Health. 2024. PMID: 39119145 Free PMC article.
Get2PrEP2-A Provider Messaging Strategy to Improve PrEP Uptake: A Randomized Controlled Quality Improvement Project.
Zucker J, Castor D, Theodore D, Carnevale C, Osilama E, Archer N, Bonadonna L, Wadden E, Morley N, Huang S, Meyers K, Cohall A, Gordon P, Sobieszczyk ME. Zucker J, et al. Among authors: theodore d. Open Forum Infect Dis. 2024 Jun 20;11(6):ofae297. doi: 10.1093/ofid/ofae297. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38911948 Free PMC article. Clinical Trial.
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial.
Sobieszczyk ME, Mannheimer S, Paez CA, Yu C, Gamble T, Theodore DA, Chege W, Yacovone M, Hanscom B, Heptinstall J, Seaton KE, Zhang L, Miner MD, Eaton A, Weiner JA, Mayer K, Kalams S, Stephenson K, Julg B, Caskey M, Nussenzweig M, Gama L, Barouch DH, Ackerman ME, Tomaras GD, Huang Y, Montefiori D; HVTN 130/HPTN 089 Study Team. Sobieszczyk ME, et al. Among authors: theodore da. Lancet HIV. 2023 Oct;10(10):e653-e662. doi: 10.1016/S2352-3018(23)00140-6. Lancet HIV. 2023. PMID: 37802566 Free PMC article. Clinical Trial.
120 results